Asia-Pacific Urinalysis Market, By Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy & Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2029
Market Analysis and Size
Urinalysis is recommended as part of the first assessment of all patients since it is simple, inexpensive, and effective. It must also be repeated when clinically necessary. Instead of being gathered over time, the urine samples have usually been taken all at once. The colour, transparency, glucose, ketones, blood, bilirubin, specific gravity, pH, protein nitrite, urobilinogen, and leukocyte esterase are measured using this method.
Data Bridge Market Research analyses that the urinalysis market which was USD 3.5 billion in 2021, would rocket up to USD 5.25 billion by 2029, and is expected to undergo a CAGR of 5.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy & Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), Analyticon Biotechnologies GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
A urine analysis is a test that is carried out to examine the pee. Because the body excretes toxins and extra fluid in the form of urine, a urine test can be used to help diagnose diseases. A urine analysis can be used to diagnose renal disease and other illnesses. It involves performing a clinical analysis of urine tests to look for certain physical characteristics including solutes, cells, casts, crystals, organisms, or particle debris.
Urinalysis Market Dynamics
Drivers
- Increase in age-associated diseases
The growing geriatric population in developing nations will benefit the market for urinalysis. The prevalence of age-related illnesses such diabetes, liver, and kidney disorders is anticipated to rise dramatically as the senior population is forecast to grow quickly. The diagnosis and treatment of such conditions has resulted in an increase in the number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin. Since urinalysis is used to perform these tests, this market is anticipated to benefit.
- Rising geriatric population
The rising geriatric population in both developed and emerging areas is the main factor driving the global market for urinalysis. Additionally, the market is growing as a result of the adaption of point-of-care diagnostics and the increased incidence of chronic diseases. Additionally, the desk-bound lifestyle of working people causes a general lack of good health among the populace in many areas, which promotes the demand for better diagnostics, including urinalysis. Therefore, the growing need for routine health checks is a key factor in the market's expansion.
- Use of urinalysis for drug tests in organisations
The widespread use of urinalysis for drug tests in organisations and at some participatory events significantly increases the market for the items. However, it is anticipated that active expansion initiatives by important firms will overcome such obstacles in the upcoming years.
Opportunities
This can be linked to the high disease prevalence, sizable patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these nations. The Asia Pacific region has become a flexible and business-friendly hub because to fewer difficult rules and data requirements than the previously mentioned criteria. Additionally, as the US and European markets mature, the majority of players are turning their attention to emerging regions. Upgrading laboratory infrastructure in emerging markets is crucially dependent on the significant investments in these nations' healthcare and life sciences research. As a result, the market for urine tests expands and encourages the installation of diagnostic equipment in laboratories.
Restraints/Challenges
- Unfavourable reimbursement scenario
The availability of refurbished instruments, which provide the same functions as new equipment at a reduced price, presents a threat to the expansion of this sector. Lack of solid regulatory frameworks could lead to an increase in the economy's consumption of second-hand goods.
- High Cost
Factors affecting the urinalysis market from growing are the high equipment cost and stringent government regulations.
This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Urinalysis Market
With the COVID-19 pandemic, there is an increasing demand for the creation of more accurate and user-friendly testing technologies, the expansion of testing infrastructures, and the development of vaccinations and therapeutic medications. Governments and healthcare providers are facing unheard-of issues as a result of COVID-19, which had an impact on the regulatory environment and procedures. Methods were used by regulatory authorities to expedite the approval of diagnostic products. In order to adopt COVID-19 rapid testing, maintain their revenues, and neutralize the influence of COVID-19 on their operational capacities, businesses have made strategic advancements.
Recent Development
- In January 2021, ARKRAY, Inc. (Japan) launched AutionIDaten AE-4070 compact automated urine analyser.
- In February 2021, 77 Elektronika Kft. (Hungary) launched LabStrip U mALB/CREA urine test strips.
Asia-Pacific Urinalysis Market Scope
The urinalysis market is segmented on the basis of testing type, product, modality, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Testing Type
- Urine Biochemistry Testing
- Urine Biochemistry Testing
Product
- Instruments
- Consumables
Modality
- Portable
- Standalone
- Table Top
- Bench Top
- Others
Application
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Pregnancy and Fertility
- Others
End User
- Hospital
- Laboratory
- Home Care Settings
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Urinalysis Market Regional Analysis/Insights
The urinalysis market is analysed and market size insights and trends are provided by country, testing type, product, modality, application and end-user as referenced above.
The countries covered in the urinalysis market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China is one of the leading countries in the world with rapidly growing diagnosis rate with increasing government initiatives for awareness regarding importance of diagnosis.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Urinalysis Market Share Analysis
The urinalysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinalysis market.
Some of the major players operating in the urinalysis market are:
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT Medical Electronic Group Co., Ltd. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatech Scientitfic E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon® Biotechnologies GmbH (Germany)
SKU-